Literature DB >> 29700612

Pigmented villonodular synovitis managed by total synovectomy and cementless total hip arthroplasty.

Mohamed Mansour Elzohairy1,2.   

Abstract

BACKGROUND: Pigmented villonodular synovitis or PVNS is a benign proliferating disease of the synovium; it behaves much as a neoplastic process does.
METHODS: This retrospective clinical study included 11 consecutive cases who underwent for total synovectomy combined with cementless total hip arthroplasty of PVNS of the hip joint.
RESULTS: The mean patient preoperative hip score of Harris was 46.1 points (range 30-70 points) improved to 94.3 points (range 90-100 points) at the last follow-up visits. No clinical or radiological evidence of recurrent PVNS or osteolysis or loosening had been detected in our patients.
CONCLUSION: Total synovectomy combined with total arthroplasty (THA) could be considered as the ideal treatment in the case of pigmented villonodular synovitis with major osteoarticular destruction and provided good results, as reported in the current series. LEVEL OF EVIDENCE: IV, case series.

Entities:  

Keywords:  Cementless; Pigmented villonodular synovitis; Synovectomy; Total hip arthroplasty

Mesh:

Year:  2018        PMID: 29700612     DOI: 10.1007/s00590-018-2214-y

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  20 in total

1.  Two to 10 Years' follow-up of arthroscopic management of pigmented villonodular synovitis in the hip: a case series.

Authors:  J W Thomas Byrd; Kay S Jones; G Peter Maiers
Journal:  Arthroscopy       Date:  2013-11       Impact factor: 4.772

2.  Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components.

Authors:  C A Engh; P Massin; K E Suthers
Journal:  Clin Orthop Relat Res       Date:  1990-08       Impact factor: 4.176

3.  The treatment of pigmented villonodular synovitis of the hip. A case report and literature review.

Authors:  S Gitelis; D Heligman; T Morton
Journal:  Clin Orthop Relat Res       Date:  1989-02       Impact factor: 4.176

4.  Acetabular defect classification and surgical reconstruction in revision arthroplasty. A 6-year follow-up evaluation.

Authors:  W G Paprosky; P G Perona; J M Lawrence
Journal:  J Arthroplasty       Date:  1994-02       Impact factor: 4.757

Review 5.  Bearing surfaces in hip replacement - Evolution and likely future.

Authors:  Narinder Kumar; Gen N C Arora; Barun Datta
Journal:  Med J Armed Forces India       Date:  2014-08-04

Review 6.  Pigmented villonodular synovitis of the hip: 2- to 23-year followup study.

Authors:  A González Della Valle; F Piccaluga; H G Potter; E A Salvati; R Pusso
Journal:  Clin Orthop Relat Res       Date:  2001-07       Impact factor: 4.176

7.  Cementless total hip arthroplasty performed in patients with pigmented villonodular synovitis.

Authors:  Jeong Joon Yoo; Young Sam Kwon; Kyung-Hoi Koo; Kang Sup Yoon; Byung Woo Min; Hee Joong Kim
Journal:  J Arthroplasty       Date:  2009-04-07       Impact factor: 4.757

Review 8.  [Pigmented villonodular synovitis of the hip. Results of a national survey apropos of 58 cases].

Authors:  R M Flipo; M C Desvigne-Noulet; A Cotten; C Fontaine; B Duquesnoy; M Lequesne; B Delcambre
Journal:  Rev Rhum Ed Fr       Date:  1994-02

9.  Low-dose external beam radiotherapy as a postoperative treatment for patients with diffuse pigmented villonodular synovitis of the knee: 4 recurrences in 23 patients followed for mean 9 years.

Authors:  Geumju Park; Young Seok Kim; Jong Hoon Kim; Sang-wook Lee; Si Yeol Song; Eun Kyung Choi; Seong Yoon Yi; Seung Do Ahn
Journal:  Acta Orthop       Date:  2012-04-11       Impact factor: 3.717

10.  Pigmented villonodular synovitis of the hip.

Authors:  Sylvain Steinmetz; Anne-Laure Rougemont; Robin Peter
Journal:  EFORT Open Rev       Date:  2017-03-13
View more
  1 in total

1.  Pigmented villonodular synovitis does not influence the outcome following cementless total hip arthroplasty using ceramic-on-ceramic articulation: a case-control study with middle-term follow-up.

Authors:  Chi Xu; Heng Guo; Kerri L Bell; Feng-Chih Kuo; Ji-Ying Chen
Journal:  J Orthop Surg Res       Date:  2018-11-20       Impact factor: 2.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.